NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.
Researchers identified 14 blood metabolites associated with cognitive function and 22 linked to brain structure changes in cognitively normal middle-aged adults, with lifestyle and gut microbiota playing significant roles in shaping these metabolite profiles. Ergothioneine emerged as a promising metabolite marker connected to cognition, potentially offering early identification targets for dementia prevention.
Researchers identified a previously unknown type of programmed cell death called karyoptosis, characterized by nuclear disintegration and driven by interaction between p38 MAP kinase and LaminB1 proteins. This mechanism was observed in approximately 35% of neurons in the frontal cortex of Alzheimer's disease patients, potentially offering new insights into neuronal loss in the disease.
Iron accumulation in the brain is being investigated as a contributing factor to neurodegenerative diseases, particularly Alzheimer's and Parkinson's disease. Scientists are studying this mechanism as part of ongoing efforts to understand the complex processes underlying these conditions affecting millions worldwide.
A study in Nature Aging identified that age-related reduction of a specific brain protein may contribute to neuronal dysfunction in Alzheimer's disease. The research examines protein-mediated mechanisms in the brain's clearance system relevant to memory loss and cognitive decline.
Research indicates that average daytime light exposure above 1,000 lux is associated with a 16% reduction in dementia risk. Getting less than 42 minutes of bright daily light exposure was found to be a stronger predictor of dementia than six conventional clinical risk factors.
